IRIS Accounts Production v24.1.0.578 13145842 director 1.1.23 31.12.23 31.12.23 false true false false true false Ordinary 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh131458422022-12-31131458422023-12-31131458422023-01-012023-12-31131458422021-12-31131458422022-01-012022-12-31131458422022-12-3113145842ns15:EnglandWales2023-01-012023-12-3113145842ns14:PoundSterling2023-01-012023-12-3113145842ns10:Director12023-01-012023-12-3113145842ns10:PrivateLimitedCompanyLtd2023-01-012023-12-3113145842ns10:SmallEntities2023-01-012023-12-3113145842ns10:AuditExemptWithAccountantsReport2023-01-012023-12-3113145842ns10:SmallCompaniesRegimeForDirectorsReport2023-01-012023-12-3113145842ns10:SmallCompaniesRegimeForAccounts2023-01-012023-12-3113145842ns10:AbridgedAccounts2023-01-012023-12-3113145842ns10:OrdinaryShareClass12023-01-012023-12-3113145842ns10:RegisteredOffice2023-01-012023-12-3113145842ns5:CurrentFinancialInstruments2023-12-3113145842ns5:CurrentFinancialInstruments2022-12-3113145842ns5:ShareCapital2023-12-3113145842ns5:ShareCapital2022-12-3113145842ns5:RetainedEarningsAccumulatedLosses2023-12-3113145842ns5:RetainedEarningsAccumulatedLosses2022-12-3113145842ns5:PlantMachinery2023-01-012023-12-3113145842ns5:FurnitureFittings2023-01-012023-12-3113145842ns5:ComputerEquipment2023-01-012023-12-3113145842ns5:DeferredTaxation2022-12-3113145842ns5:DeferredTaxation2023-01-012023-12-3113145842ns5:DeferredTaxation2023-12-3113145842ns10:OrdinaryShareClass12023-12-31
REGISTERED NUMBER: 13145842 (England and Wales)















FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2023

FOR

PURE DERMAL LIMITED

PURE DERMAL LIMITED (REGISTERED NUMBER: 13145842)






CONTENTS OF THE FINANCIAL STATEMENTS
for the Year Ended 31 December 2023




Page

Company Information 1

Abridged Balance Sheet 2

Notes to the Financial Statements 4

Report of the Accountants 6

PURE DERMAL LIMITED

COMPANY INFORMATION
for the Year Ended 31 December 2023







DIRECTOR: Mrs S M Round



REGISTERED OFFICE: 1 Oak Street
Kingswinford
West Midlands
DY6 9LS



REGISTERED NUMBER: 13145842 (England and Wales)



ACCOUNTANTS: Bradley Rhodes Limited
Beechcroft House
50 Sedgley Road West
Tipton
West Midlands
DY4 8AB



BANKERS: Lloyds Bank plc
115 Victoria Road
Aldershot
Hampshire
GU11 1JQ

PURE DERMAL LIMITED (REGISTERED NUMBER: 13145842)

ABRIDGED BALANCE SHEET
31 December 2023

2023 2022
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 3,120 4,068

CURRENT ASSETS
Stocks 2,895 3,650
Cash at bank 5,832 2,477
8,727 6,127
CREDITORS
Amounts falling due within one year 6,277 8,186
NET CURRENT ASSETS/(LIABILITIES) 2,450 (2,059 )
TOTAL ASSETS LESS CURRENT
LIABILITIES

5,570

2,009

PROVISIONS FOR LIABILITIES 5 593 773
NET ASSETS 4,977 1,236

CAPITAL AND RESERVES
Called up share capital 6 100 100
Retained earnings 4,877 1,136
SHAREHOLDERS' FUNDS 4,977 1,236

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 December 2023.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 December 2023 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges her responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

PURE DERMAL LIMITED (REGISTERED NUMBER: 13145842)

ABRIDGED BALANCE SHEET - continued
31 December 2023


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

All the members have consented to the preparation of an abridged Income Statement and an abridged Balance Sheet for the year ended 31 December 2023 in accordance with Section 444(2A) of the Companies Act 2006.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director and authorised for issue on 19 September 2024 and were signed by:





Mrs S M Round - Director


PURE DERMAL LIMITED (REGISTERED NUMBER: 13145842)

NOTES TO THE FINANCIAL STATEMENTS
for the Year Ended 31 December 2023

1. STATUTORY INFORMATION

Pure Dermal Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Plant and machinery - 20% on reducing balance
Fixtures and fittings - 20% on reducing balance
Computer equipment - 33% on cost

Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 1 (2022 - 1 ) .

PURE DERMAL LIMITED (REGISTERED NUMBER: 13145842)

NOTES TO THE FINANCIAL STATEMENTS - continued
for the Year Ended 31 December 2023

4. TANGIBLE FIXED ASSETS
Totals
£   
COST
At 1 January 2023
and 31 December 2023 5,080
DEPRECIATION
At 1 January 2023 1,012
Charge for year 948
At 31 December 2023 1,960
NET BOOK VALUE
At 31 December 2023 3,120
At 31 December 2022 4,068

5. PROVISIONS FOR LIABILITIES
2023 2022
£    £   
Deferred tax 593 773

Deferred
tax
£   
Balance at 1 January 2023 773
Provided during year (180 )
Balance at 31 December 2023 593

6. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 2023 2022
value: £    £   
100 Ordinary £1 100 100

PURE DERMAL LIMITED

REPORT OF THE ACCOUNTANTS TO THE DIRECTOR OF
PURE DERMAL LIMITED

The following reproduces the text of the report prepared for the director in respect of the company's annual unaudited financial statements. In accordance with the Companies Act 2006, the company is only required to file a Balance Sheet. Readers are cautioned that the Abridged Income Statement and certain other primary statements and the Report of the Director are not required to be filed with the Registrar of Companies.

As described on the Balance Sheet you are responsible for the preparation of the financial statements for the year ended 31 December 2023 set out on pages three to eight and you consider that the company is exempt from an audit.

In accordance with your instructions, we have compiled these unaudited financial statements in order to assist you to fulfil your statutory responsibilities, from the accounting records and information and explanations supplied to us.






Bradley Rhodes Limited
Beechcroft House
50 Sedgley Road West
Tipton
West Midlands
DY4 8AB


19 September 2024